Labiotech.eu

bluebird bio gene therapy beta thalassemia

News and Trends 4 Jun 2019

First Gene Therapy for Beta Thalassemia Approved in Europe

The US biotech company bluebird bio has obtained EU conditional market approval for a gene therapy that could remove the need for blood transfusions for people with the blood disorder beta-thalassemia. Called Zynteglo, the gene therapy is aimed at treating people with beta-thalassemia who are over 12 years of age and have any but the […]

June 4, 2019 - 3 minutesmins - By Jonathan Smith

In Depth 4 Jun 2019

Ultra-Fast Diagnostics Could Transform Sexual Health

Each day more than one million people around the world acquire sexually transmitted infections, with a profound impact on sexual and reproductive health across the globe. Biotechs across Europe are developing rapid diagnostics for some of the most common STIs. It’s difficult to comprehend the sheer scale of the number of people affected by sexually […]

June 4, 2019 - 7 minutesmins - By David Cox

News and Trends 3 Jun 2019

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR T-cell therapies in patients to better manage side effects. CAR T-cell therapies have revolutionized the way we treat cancer. Instead of giving the patient a classical drug, companies can inject them with living, genetically engineered cells that kill cancer cells. […]

June 3, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 3 Jun 2019

‘CRISPR Babies’ Might Be at Risk of Dying Younger

Update (01/10/2019): The scientists behind the study have declared that the results were based on erroneous data, meaning the mutation they studied has a weaker effect on mortality than initially reported. A new study highlights the issues that can result from modifying human DNA without sufficient understanding of how it can impact our health. Last […]

June 3, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

kiadis pharma bone marrow transplant cell therapy

News and Trends 3 Jun 2019

Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market

The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical development of immune cell therapies treating blood cancer. The money will fund phase III trials of Kiadis’ lead candidate cell therapy for blood cancer, aimed to get European approval by the end of 2019. In addition, the cash will boost […]

June 3, 2019 - 2 minutesmins - By Jonathan Smith

pure biologics wroclaw devics disease 1 1

Startup Scout 31 May 2019

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing DNA molecules that could treat the incurable neurological condition Devic’s disease with fewer side effects than existing treatments. Mission: To develop a treatment that makes an existing treatment for Devic’s disease, plasmapheresis, more targeted and with fewer side effects than […]

May 31, 2019 - 4 minutesmins - By Jonathan Smith

Interview 30 May 2019

Taking Inspiration from Plants to Prevent Mold from Ruining Crops

Olga Dubey founded the Swiss startup Agrosustain with the intention to bring forth a natural alternative to chemical pesticides against mold. She shares how it all started and her company’s plans to end the massive amounts of food waste that mold is responsible for. “Mold is everywhere, so it’s something that is very hard to […]

May 30, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

gensight gene therapy lhon genetic blindness

News and Trends 29 May 2019

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

The French biotech GenSight will apply for regulatory approval for its gene therapy despite the treatment unexpectedly resulting in the improvement of the eyes treated with a placebo in a phase III trial. GenSight is developing a gene therapy designed to treat progressive vision loss caused by the rare genetic condition Leber hereditary optic neuropathy. […]

May 29, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 29 May 2019

€60M Investment to Boost Oxford Biomedica’s Gene and Cell Therapies

The Danish investor Novo Holdings is handing Oxford Biomedica up to €60.6M (£53.5M) to develop gene and cell therapies treating cancer and genetic blindness. The investment will bag Novo Holdings a stake of up to 10.1% in the UK biotech. Oxford Biomedica will use the money to repay a loan totalling €49M ($55M) from the […]

May 29, 2019 - 2 minutesmins - By Jonathan Smith

nanobiotix nanotechnology nanoparticle cancer

More News! 28 May 2019

Nanomedicine Company Launches in France to Improve Drug Safety

The French nanomedicine biotech Nanobiotix is spinning out a subsidiary company developing nanoparticles that can enhance a drug’s effectiveness and decrease side effects. Called Curadigm, the spinout will be developing nanotechnology with the potential to make low drug doses more effective at treating different conditions, which could make treatments cheaper and with fewer side effects […]

May 28, 2019 - 2 minutesmins - By Jonathan Smith

Interview 28 May 2019

Getting Ahead of the Pack in the CAR-T Field

Celyad is one of many companies in the immuno-oncology field seeking to take the lead in the development of a new generation of CAR-T cell therapy that outperforms its predecessors Yescarta and Kymriah in both efficacy and safety. Filippo Petti, CEO of Celyad, shares the company’s strategy to get ahead in such a crowded field. […]

May 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

small respiratory syncytial virus alzheimers disease sweden 1

News and Trends 28 May 2019

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

Scientists in Sweden have found that some viruses can increase the buildup of protein ‘plaques’ linked to Alzheimer’s disease, a discovery that could lead to new vaccines treating the condition. According to Kariem Ezzat, one of the lead researchers based in Stockholm University, the group is looking for industrial collaborators to develop vaccines against viruses […]

May 28, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

First Gene Therapy for Beta Thalassemia Approved in Europe

Ultra-Fast Diagnostics Could Transform Sexual Health

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

‘CRISPR Babies’ Might Be at Risk of Dying Younger

Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

Taking Inspiration from Plants to Prevent Mold from Ruining Crops

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

€60M Investment to Boost Oxford Biomedica’s Gene and Cell Therapies

Nanomedicine Company Launches in France to Improve Drug Safety

Getting Ahead of the Pack in the CAR-T Field

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!